ROYAL BANK OF CANADA - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,000
-54.8%
14,930
+15.9%
0.00%
Q2 2023$42,000
+100.0%
12,881
+146.6%
0.00%
Q1 2023$21,000
-72.4%
5,224
-60.3%
0.00%
Q4 2022$76,000
+322.2%
13,165
+372.0%
0.00%
Q3 2022$18,000
+800.0%
2,789
+464.6%
0.00%
Q2 2022$2,000
-88.9%
494
-88.8%
0.00%
Q1 2022$18,000
-80.9%
4,397
-70.9%
0.00%
Q4 2021$94,000
+42.4%
15,098
+117.5%
0.00%
Q3 2021$66,000
+3.1%
6,941
+47.2%
0.00%
Q2 2021$64,000
-1.5%
4,715
+18.1%
0.00%
Q1 2021$65,000
+490.9%
3,993
+848.5%
0.00%
Q4 2020$11,000
+450.0%
421
+347.9%
0.00%
Q3 2020$2,000
-33.3%
94
-16.1%
0.00%
Q2 2020$3,000
+200.0%
112
-26.3%
0.00%
Q1 2020$1,000
-94.7%
152
-95.4%
0.00%
Q4 2019$19,000
+1800.0%
3,282
+435.4%
0.00%
Q3 2019$1,000
-83.3%
613
-61.0%
0.00%
Q2 2019$6,000
+200.0%
1,572
+546.9%
0.00%
Q3 2018$2,000
-33.3%
243
+62.0%
0.00%
Q2 2018$3,000
+200.0%
150
+240.9%
0.00%
Q4 2017$1,000
-83.3%
44
-87.6%
0.00%
Q3 2017$6,0003540.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders